Original Brand drug
Epclusa （Sofosbuvir/Velpatasvir） is the world’s first all-oral, pan-genotypic, single-tablet hepatitis C treatment regimen, taken orally once daily, for all 6 genotypes (GT-1, -2, -3, -4, -5,-6) Treatment of hepatitis C patients.
Currently, there are 26 versions of sofosbuvir/velpatasvir tablets available in the Asia-Pacific region.
Generic Drugs
- Indian Natco：Hepcinat （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Indian Natco：Velsof （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Indian Hetero Drugs Ltd：Velasof（Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Indian Hetero Drugs Ltd：Велсоф（Противомикробные/Противовирусные）400mg/100mg tablets
- Indian Cipla Ltd：HEPCVEL（Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Indian Zydus Cadila：SoviHep V（Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Indian Cadila Healthcare Ltd (Zydus)：Velakast （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Indian Dr Reddy’s Lab: Resof （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Indian Mylan Pharma: MYHep All （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Indian Abbott: Velpaclear （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Indian Torrent Pharma: Velpacruz S（Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Indian Emcure Pharma:Sofocure v（Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Indian Taj Pharma: Hepcitaj-SV （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Indian Stride Pharma: VIRVEL （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Indian Healthiza Life: Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Bangladesh Beacon Pharma: Sofosvel （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Bangladesh Incepta Pharma-Sofosbuvir/Velpatasvir-Panovir （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Bangladesh Everest Pharma-Sofosbuvir/Velpatasvir-Velpanex （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Bangladesh Drug International limted(DIL): HopeSo-VL （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Pakistan Getz Pharma: Velpaget （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Pakistan Sami Pharma: Ocvir-V （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Pakistan Aspin Pharma: Sofvel （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Pakistan Scotmann Pharma: Velscot （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Pakistan Genix Pharma: Velso （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Pakistan Hilton Pharma: Hilvel （Sofosbuvir/Velpatasvir）400mg/100mg tablets
- Lao Tongmeng Pharmaceutical & Food Co., Ltd.（TLPH）: Gienoe （Sofosbuvir/Velpatasvir）400mg/100mg tablets
Sofosbuvir-velpatasvir Other Names: SOF-VEL、Velpatasvir. The fixed-dose combination SOF-VEL (400 mg/100 mg) is FDA-approved for the treatment of chronic hepatitis C genotypes 1 to 6 for the following patient populations:
- Patients without cirrhosis and patients with compensated cirrhosis (Child-Pugh A): sofosbuvir-velpatasvir for 12 weeks
- Patients with decompensated cirrhosis (Child-Pugh B and C): sofosbuvir-velpatasvir plus ribavirin for 12 weeks
Sofosbuvir-velpatasvir is available as a coformulated, once-daily single-pill combination of sofosbuvir 400 mg and velpatasvir 100 mg. The recommended dose is one tablet once daily, taken with or without food.
Unlocking Global Health Opportunities: Mitotane (MITODX)
8 fármacos dirigidos para el tratamiento de la leucemia linf…
8 targeted drugs for treatment of the Chronic lymphocytic le…
4 fármacos dirigidos para el tratamiento del Carcinoma Endom…
